Back to News
Market Impact: 0.25
HeartBeam's 3D ECG Shows Promising Results In Heart Attack Assessment Pilot Study
Source: Nasdaq
Healthcare & BiotechTechnology & InnovationCompany Fundamentals
HeartBeam announced positive results from its ALIGN-ACS pilot study evaluating a portable 3D ECG system for heart attack assessment. The brief report provides no numerical results or further study details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
BEAT0.65
More News
- Marvell to buy Lumentum in $115 billion deal in AI data-center bet
- Marvell, Lumentum tout historic $115B deal to create ‘category leader' in AI connectivity
- Palantir reports booming U.S. commercial revenue growth, topping government for first time
- Anthropic releases amended IPO prospectus with third-quarter financials
- Coinbase has been battered over the past month. Morgan Stanley says steer clear
- The AI boom is facing another supply crunch. This time it’s the amount of capital available to feed Silicon Valley’s endless need for cash